Effect of PKC412, a selective inhibitor of protein kinase C, on lung metastasis in mice injected with B16 melanoma cells

Life Sciences

Volumn 72, Issue 12, 2003, Pages 1377-1387

  Yoshikawa, Noriko ^a   Nakamura, Kazuki ^a   Yamaguchi, Yu ^a   Kagota, Satomi ^a   Shinozuka, Kazumasa ^a   Kunitomo, Masaru ^a  

^a MUKOGAWA WOMEN'S UNIVERSITY   (Japan)

Author keywords

Anti metastasis; B16 mouse melanoma cells; Chemo invasion; PKC inhibitor; Platelet aggregation

Indexed keywords

ANTIMETASTATIC AGENT; MIDOSTAURIN; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CANCER INVASION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; FEMALE; GROWTH CURVE; LUNG METASTASIS; MELANOMA CELL; METASTASIS INHIBITION; MOUSE; NONHUMAN; THROMBOCYTE AGGREGATION;

ANIMALS; CELL DIVISION; ENZYME INHIBITORS; FEMALE; LUNG NEOPLASMS; MALE; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; PLATELET AGGREGATION; PROTEIN KINASE C; RABBITS; STAUROSPORINE; TUMOR CELLS, CULTURED;

EID: 0037422933     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(02)02407-4     Document Type: Article

References (20)

1. Nishizuka Y. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science. 258:1992;607-614.
2. Hofmann J. The potential for isoenzyme-selective modulation of protein kinase C. FASEB Journal. 11:1997;649-669.
3. Liu W.S., Heckman C.A. The sevenfold way of PKC regulation. Cell Signal. 10:1998;529-542.
4. O'Brian C., Vogel V.G., Singletary S.E., Ward N.E. Elevated protein kinase C expression in human breast tumor biopsies relative to normal breast tissue. Cancer Research. 49:1989;3215-3217.
5. Benzil D.L., Finkelstein S.D., Epstein M.H., Finch P.W. Expression pattern of alpha-protein kinase C in human astrocytomas indicates a role in malignant progression. Cancer Research. 52:1992;2951-2956.
6. La Porta C.A.M., Comolli R. Activation of protein kinase C-α isoform in murine melanoma cells with high metastatic potential. Clinical and Experimental Metastasis. 15:1997;568-579.
7. Meyer T., Regenass U., Fabbro D., Alteri E., Rösel J., Müller M., Caravatti G., Matter A. A derivative of staurosporine (CGP41251) shows selectivity for protein kinase C inhibition and in vitro anti-proliferative as well as in vivo anti-tumor activity. International Journal of Cancer. 43:1989;851-856.
8. Fabbro D., Buchdunger E., Wood J., Mestan J., Hofmann F., Ferrari S., Mett H., O'Reilly T., Meyer T. Inhibitors of protein kinases: CGP41251, a protein kinase inhibitor with potential as an anticancer agent. Pharmacology and Therapeutics. 82:1999;293-301.
9. Propper D.J., McDonald A.C., Man A., Thavasu P., Balkwill F., Braybrooke J.P., Caponigro F., Graf P., Dutreix C., Blackie R., Kaye S.B., Ganesan T.S., Talbot D.C., Harris A.L., Twelves C. Phase I and pharmacokinetic study of PKC412, an inhibitor of protein kinase C. Journal of Clinical Oncology. 19:2001;1485-1492.
10. Fidler I.J. Selection of successive tumor lines for metastasis. Nature New Biology. 242:1973;148-149.
11. Poste G., Doll J., Fidler I.J. In vitro selection of murine B16 melanoma variants with enhanced tissue-invasive properties. Cancer Research. 40:1980;1636-1644.
12. Albini A., Iwamoto Y., Kleinman H.K., Martin G.R., Aaronson S.S., Kozlowski J.M., McEwan R.N. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Research. 47:1987;3239-3245.
13. Ma L.D., Marquardt D., Takemoto L., Center M.S. Analysis of P-glycoprotein phosphorylation in HL60 cells isolated for resistance to vincristine. Journal of Biological Chemistry. 266:1991;5593-5599.
14. Blobe G.C., Sachs C.W., Khan W.A., Fabbro D., Stabel S., Wetsel W.C., Obeid L.M., Fine R.L., Hannun Y.A. Selective regulation of expression of protein kinase C isoenzymes in multidrug-resistance MCF-7 cells, Functional significance of enhanced expression of PKC-α Journal of Biological Chemistry. 268:1993;658-664.
15. Utz I., Hofer S., Regenass U., Hilbe W., Thaler J., Grunicke H., Hofmann J. The protein kinase C inhibitor CGP41251, a staurosporine derivative with antitumor activity, reverses multidrug resistance. International Journal of Cancer. 57:1994;104-110.
16. Beltran P.J., Fan D., Fidler I.J., O'Brian C.A. Chemosensitization of cancer cells by the staurosporine derivative CGP41251 in association with decreased P-glycoprotein phosphorylation. Biochemical Pharmacology. 53:1997;245-247.
17. Nakamura K., Shinozuka K., Kunitomo M. Suppressive effect of protein kinase C inhibitors on tumor cell function via phosphorylation of p53 protein in mice. Yakugaku Zasshi. 120:2000;1387-1394.
18. Fabbro D., Ruetz S., Bodis S., Pruschy M., Csermak K., Man A., Campochiaro P., Wood J., O'Reilly T., Meyer T. PKC412-a protein kinase inhibitor with a broad therapeutic potential. Anti-Cancer Drug Design. 15:2000;17-28.
19. Koike C., Watanabe M., Isoai A., Kumagai H., Tsukada H., Irimura T., Okada S., Oku N. How platelet aggregation affects B16BL6 melanoma cell trafficking. FEBS Letters. 427:1998;286-290.
20. Sullivan R.M., Stone M., Marshall J.F., Uberall F., Rotenberg S.A. Photo-induced inactivation of protein kinase Cα by dequalinium inhibits motility of murine melanoma cells. Molecular Pharmacology. 58:2000;729-737.